特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
968855

経皮パッチの世界市場の分析:2020年

Global Transdermal Patch Market Professional Survey Report 2020

出版日: | 発行: QYResearch | ページ情報: 英文 116 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.83円
経皮パッチの世界市場の分析:2020年
出版日: 2020年11月06日
発行: QYResearch
ページ情報: 英文 116 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の経皮パッチ市場は、2019年の67億4,500万米ドルから、2026年末までに79億2,900万米ドルに達し、2020年~2026年のCAGRで3.56%の成長が予測されています。

当レポートでは、世界の経皮パッチ市場について調査分析し、市場規模 (数量・金額) 、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

目次

第1章 経皮パッチの業界概要

  • 定義
  • セグメント:タイプ別
    • 世界の売上成長率比較:タイプ別
    • サリチル酸メチルベースパッチ
    • リバスチグミン経皮パッチ
    • フェンタニル経皮パッチ
    • リドカインパッチ
    • ジクロフェナクパッチ
    • ニコチン経皮パッチ
  • セグメント:用途別
    • Rx薬
    • OTC薬
  • 世界の市場全体

第2章 製造コスト構造分析

  • 原材料とサプライヤー
  • 製造コスト構造分析
  • 製造工程分析
  • 業界チェーン構造

第3章 経皮パッチの開発・製造プラント分析

  • 主要メーカーの本社、ランキング:売上別
  • 世界の製造工場の分布
  • 主要メーカーの提供製品
  • 最近の開発・拡張計画

第4章 主要メーカーの主要数値

  • 世界の主要メーカーの売上分析
  • 世界の主要メーカーの収益分析
  • 世界の主要メーカーの価格分析
  • 市場集中度
  • 主要企業への主要インタビュー

第5章 経皮パッチ地域別市場分析

  • 売上:地域別
  • 売上予測:地域別
  • 北米の市場分析
  • 欧州の市場分析
  • 中国の市場分析
  • 日本の市場分析
  • 南米の市場分析

第6章 経皮パッチセグメント市場分析(タイプ別)

  • 世界の市場規模:タイプ別
  • 世界の市場規模予測:タイプ別
  • 価格:タイプ別

第7章 経皮パッチセグメント市場分析(用途別)

  • 概要
  • 世界の収益の市場シェア:用途別
  • 世界の収益予測の市場シェア:用途別

第8章 経皮パッチの主要メーカー分析

  • Hisamitsu Pharmaceutical
  • Johnson & Johnson
  • Novartis
  • UCB Pharma
  • Mylan
  • Teva Pharmaceutical
  • Nitto Denko
  • Grunenthal
  • IBSA Group
  • GSK
  • Luye Pharma Group
  • Pfizer
  • Chattem
  • Dr Reddy's Laboratories
  • Bayer
  • Mundipharma
  • Endo International
  • Beijing Tide Pharmaceutical

第9章 マーケティングチャネル・ディストリビューター・顧客

  • マーケティングチャネル
  • ディストリビューターリスト
  • 顧客

第10章 市場力学

  • 市場動向
  • 機会と促進要因
  • 市場課題
  • ポーターのファイブフォース分析

第11章 結論

第12章 付録

図表

List of Tables and Figures

  • Table 1. Global Transdermal Patch Market Size Growth Rate by Type (2015-2026) & (M Pieces) 2
  • Table 2. Global Transdermal Patch Sales (M Pieces) Comparison by Application (2015-2026) 6
  • Table 3. Global Transdermal Patch Market Size by Region in US$ Million: 2015 VS 2020 VS 2026 8
  • Table 4. Key Suppliers of Raw Materials 16
  • Table 5. Transdermal Patch Sales Rank of Key Players 21
  • Table 6. Global Transdermal Patch Manufacturing Plants Distribution 22
  • Table 7. Transdermal Patch Major Manufacturers Transdermal Patch Product Offered 22
  • Table 8. Recent Development and Expansion Plans in Future 23
  • Table 9. Global Transdermal Patch Manufacturers Covered in This report: Sales, Revenue and Market Share in 2019 25
  • Table 10. Global Transdermal Patch Sales (M Pieces) of Major Manufacturers (2015-2020) 26
  • Table 11. Transdermal Patch Sales Market Share of Major Manufacturers (2015-2020) 27
  • Table 12. Global Transdermal Patch Revenue (US$ Million) of Major Manufacturers (2015-2020) 28
  • Table 13. Transdermal Patch Revenue Market Share of Major Manufacturers (2015-2020) 29
  • Table 14. Global Transdermal Patch Average Price (USD/Piece) of Major Manufacturers (2015-2020) 32
  • Table 15. Main Points Interviewed from Key Transdermal Patch Players 33
  • Table 16. Global Transdermal Patch Sales by Regions (2015-2020) & (M Pieces) 34
  • Table 17. Global Transdermal Patch Sales Market Share by Regions (2015-2020) 34
  • Table 18. Global Transdermal Patch Revenue by Regions (2015-2020) & (US$ Million) 35
  • Table 19. Global Transdermal Patch Revenue Market Share by Regions (2015-2020) 35
  • Table 20. Global Transdermal Patch Sales by Regions (2021-2026) & (M Pieces) 36
  • Table 21. Global Transdermal Patch Sales Market Share by Regions (2021-2026) 37
  • Table 22. Global Transdermal Patch Revenue by Regions (2021-2026) & (US$ Million) 37
  • Table 23. Global Transdermal Patch Revenue Market Share by Regions (2021-2026) 37
  • Table 24. Global Transdermal Patch Sales by Type (2015-2020) & (M Pieces) 43
  • Table 25. Global Transdermal Patch Sales Share by Type (2015-2020) 43
  • Table 26. Global Transdermal Patch Revenue by Type (2015-2020) & (US$ Million) 43
  • Table 27. Global Transdermal Patch Revenue Share by Type (2015-2020) 44
  • Table 28. Global Transdermal Patch Sales by Type (2021-2026) & (M Pieces) 44
  • Table 29. Global Transdermal Patch Sales Share by Type (2021-2026) 44
  • Table 30. Global Transdermal Patch Revenue by Type (2021-2026) & (US$ Million) 45
  • Table 31. Global Transdermal Patch Revenue Share by Type (2021-2026) 45
  • Table 32. Transdermal Patch Price by Type (2015-2020) & (USD/Piece) 45
  • Table 33. Transdermal Patch Price by Type (2021-2026) & (USD/Piece) 46
  • Table 34. Global Transdermal Patch Sales by Application (2015-2020) & (M Pieces) 47
  • Table 35. Global Transdermal Patch Sales Share by Application (2015-2020) 47
  • Table 36. Global Transdermal Patch Sales by Application (2021-2026) & (M Pieces) 47
  • Table 37. Global Transdermal Patch Sales Share by Application (2021-2026) 48
  • Table 38. Hisamitsu Pharmaceutical Corporation Information 49
  • Table 39. Hisamitsu Pharmaceutical Transdermal Patch Sales (M Pieces), Revenue (US$ Million), Ex-factory Price (USD/Piece) and Gross Margin (2015-2020) 50
  • Table 40. Hisamitsu Pharmaceutical Transdermal Patch Product 50
  • Table 41. Johnson & Johnson Corporation Information 51
  • Table 42. Johnson & Johnson Transdermal Patch Sales (M Pieces), Revenue (US$ Million), Ex-factory Price (USD/Piece) and Gross Margin (2015-2020) 52
  • Table 43. Johnson & Johnson Transdermal Patch Product 53
  • Table 44. Novartis Corporation Information 54
  • Table 45. Novartis Transdermal Patch Sales (M Pieces), Revenue (US$ Million), Ex-factory Price (USD/Piece) and Gross Margin (2015-2020) 55
  • Table 46. Novartis Transdermal Patch Product 55
  • Table 47. UCB Pharma Corporation Information 56
  • Table 48. UCB Pharma Transdermal Patch Sales (M Pieces), Revenue (US$ Million), Ex-factory Price (USD/Piece) and Gross Margin (2015-2020) 57
  • Table 49. UCB Pharma Transdermal Patch Product 57
  • Table 50. Mylan Corporation Information 57
  • Table 51. Mylan Transdermal Patch Sales (M Pieces), Revenue (US$ Million), Ex-factory Price (USD/Piece) and Gross Margin (2015-2020) 58
  • Table 52. Mylan Transdermal Patch Product 58
  • Table 53. Teva Pharmaceutical Corporation Information 59
  • Table 54. Teva Pharmaceutical Transdermal Patch Sales (M Pieces), Revenue (US$ Million), Ex-factory Price (USD/Piece) and Gross Margin (2015-2020) 60
  • Table 55. Teva Pharmaceutical Transdermal Patch Product 61
  • Table 56. Nitto Denko Corporation Information 61
  • Table 57. Nitto Denko Transdermal Patch Sales (M Pieces), Revenue (US$ Million), Ex-factory Price (USD/Piece) and Gross Margin (2015-2020) 62
  • Table 58. Nitto Denko Transdermal Patch Product 62
  • Table 59. Grunenthal Corporation Information 63
  • Table 60. Grunenthal Transdermal Patch Sales (M Pieces), Revenue (US$ Million), Ex-factory Price (USD/Piece) and Gross Margin (2015-2020) 64
  • Table 61. Grunenthal Transdermal Patch Product 64
  • Table 62. IBSA Group Corporation Information 64
  • Table 63. IBSA Group Transdermal Patch Sales (M Pieces), Revenue (US$ Million), Ex-factory Price (USD/Piece) and Gross Margin (2015-2020) 65
  • Table 64. IBSA Group Transdermal Patch Product 66
  • Table 65. GSK Corporation Information 66
  • Table 66. GSK Transdermal Patch Sales (M Pieces), Revenue (US$ Million), Ex-factory Price (USD/Piece) and Gross Margin (2015-2020) 67
  • Table 67. GSK Transdermal Patch Product 67
  • Table 68. Luye Pharma Group Corporation Information 68
  • Table 69. Luye Pharma Group Transdermal Patch Sales (M Pieces), Revenue (US$ Million), Ex-factory Price (USD/Piece) and Gross Margin (2015-2020) 69
  • Table 70. Luye Pharma Group Transdermal Patch Product 69
  • Table 71. Pfizer Corporation Information 70
  • Table 72. Pfizer Transdermal Patch Sales (M Pieces), Revenue (US$ Million), Ex-factory Price (USD/Piece) and Gross Margin (2015-2020) 70
  • Table 73. Pfizer Transdermal Patch Product 71
  • Table 74. Chattem Corporation Information 71
  • Table 75. Chattem Transdermal Patch Sales (M Pieces), Revenue (US$ Million), Ex-factory Price (USD/Piece) and Gross Margin (2015-2020) 72
  • Table 76. Chattem Transdermal Patch Product 73
  • Table 77. Dr Reddy's Laboratories Corporation Information 73
  • Table 78. Dr Reddy's Laboratories Transdermal Patch Sales (M Pieces), Revenue (US$ Million), Ex-factory Price (USD/Piece) and Gross Margin (2015-2020) 74
  • Table 79. Dr Reddy's Laboratories Transdermal Patch Product 74
  • Table 80. Bayer Corporation Information 75
  • Table 81. Bayer Transdermal Patch Sales (M Pieces), Revenue (US$ Million), Ex-factory Price (USD/Piece) and Gross Margin (2015-2020) 76
  • Table 82. Bayer Transdermal Patch Product 76
  • Table 83. Mundipharma Corporation Information 77
  • Table 84. Mundipharma Transdermal Patch Sales (M Pieces), Revenue (US$ Million), Ex-factory Price (USD/Piece) and Gross Margin (2015-2020) 78
  • Table 85. Mundipharma Transdermal Patch Product 78
  • Table 86. Endo International Corporation Information 79
  • Table 87. Endo International Transdermal Patch Sales (M Pieces), Revenue (US$ Million), Ex-factory Price (USD/Piece) and Gross Margin (2015-2020) 80
  • Table 88. Endo International Transdermal Patch Product 80
  • Table 89. Beijing Tide Pharmaceutical Corporation Information 81
  • Table 90. Beijing Tide Pharmaceutical Transdermal Patch Sales (M Pieces), Revenue (US$ Million), Ex-factory Price (USD/Piece) and Gross Margin (2015-2020) 82
  • Table 91. Beijing Tide Pharmaceutical Transdermal Patch Product 83
  • Table 92. Transdermal Patch Distributors List 85
  • Table 93. Transdermal Patch Customers List 87
  • Table 94. Transdermal Patch Market Trends 90
  • Table 95. Transdermal Patch Market Opportunities and Drivers 91
  • Table 96. Transdermal Patch Market Challenges 92
  • Table 97. Research Programs/Design for This Report 96
  • Table 98. Key Data Information from Secondary Sources 99
  • Table 99. Key Data Information from Primary Sources 101
  • Figure 1. Picture of Transdermal Patch 1
  • Figure 2. Global Transdermal Patch Market Share by Type in 2019 2
  • Figure 3. Methyl Salicylate-based Patch Product Picture 3
  • Figure 4. Rivastigmine Transdermal Patch Product Picture 3
  • Figure 5. Fentanyl Transdermal Patch Product Picture 4
  • Figure 6. Lidocaine Patch Product Picture 5
  • Figure 7. Diclofenac Patch Product Picture 5
  • Figure 8. Nicotine Transdermal Patch Product Picture 6
  • Figure 9. Global Transdermal Patch Market Share by Application in 2019 7
  • Figure 10. Rx Channel 7
  • Figure 11. OTC Channel 8
  • Figure 12. Global Transdermal Patch Market Share Scenario by Region in Percentage (2015-2026) 9
  • Figure 13. Global Transdermal Patch Revenue, (US$ Million), 2015 VS 2020 VS 2026 10
  • Figure 14. Global Transdermal Patch Revenue (US$ Million) (2015-2026) 10
  • Figure 15. Global Transdermal Patch Sales (M Pieces) & (2015-2026) 11
  • Figure 16. North America Transdermal Patch Revenue (US$ Million) Growth Rate (2015-2026) 12
  • Figure 17. Europe Transdermal Patch Revenue (US$ Million) Growth Rate (2015-2026) 13
  • Figure 18. China Transdermal Patch Revenue (US$ Million) Growth Rate (2015-2026) 13
  • Figure 19. Japan Transdermal Patch Revenue (US$ Million) Growth Rate (2015-2026) 14
  • Figure 20. South America Transdermal Patch Revenue (US$ Million) Growth Rate (2015-2026) 15
  • Figure 21. Manufacturing Cost Structure Analysis of Transdermal Patch in 2019 17
  • Figure 22. Manufacturing Process Analysis of Transdermal Patch 19
  • Figure 23. Industry Chain Structure of Transdermal Patch 20
  • Figure 24. Transdermal Patch Sales Share by Manufacturers in 2019 28
  • Figure 25. Transdermal Patch Revenue Share by Manufacturers in 2019 31
  • Figure 26. The Top 5 Players Market Share by Transdermal Patch Revenue in 2019 33
  • Figure 27. Global Transdermal Patch Sales Market Share by Regions in 2019 35
  • Figure 28. Global Transdermal Patch Revenue Market Share by Regions in 2019 36
  • Figure 29. North America Transdermal Patch Sales Growth Rate 2015-2026 (M Pieces) 38
  • Figure 30. Europe Transdermal Patch Sales Growth Rate 2015-2026 (M Pieces) 39
  • Figure 31. China Transdermal Patch Sales Growth Rate 2015-2026 (M Pieces) 40
  • Figure 32. Japan Transdermal Patch Sales Growth Rate 2015-2026 (M Pieces) 41
  • Figure 33. South America Transdermal Patch Sales Growth Rate 2015-2026 (M Pieces) 42
  • Figure 34. Channels of Distribution 85
  • Figure 35. Distributors Profiles 87
  • Figure 36. GDP Forecast to 2040 91
  • Figure 37. Porter's Five Forces Analysis 93
  • Figure 38. Bottom-up and Top-down Approaches for This Report 98
  • Figure 39. Data Triangulation 99
  • Figure 40. Key Executives Interviewed 101
目次

The global Transdermal Patch market was valued at US$ 6745 million in 2019 and will reach US$ 7929 million by the end of 2026, growing at a CAGR of 3.56% during 2020-2026.

This report focuses on Transdermal Patch volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Transdermal Patch market size by analyzing historical data and future prospect. Regionally, this report categorizes the sales of Transdermal Patch in North America, Europe, China, Japan, etc.

For the manufacturers covered, this report analyzes the Transdermal Patch manufacturing sites, sales, ex-factory price, revenue and market share for each company.

By Company

  • Hisamitsu Pharmaceutical
  • Johnson & Johnson
  • Novartis
  • UCB Pharma
  • Mylan
  • Teva Pharmaceutical
  • Nitto Denko
  • Grunenthal
  • IBSA Group
  • GSK
  • Luye Pharma Group
  • Pfizer
  • Chattem
  • Dr Reddy's Laboratories
  • Bayer
  • Mundipharma
  • Endo International
  • Beijing Tide Pharmaceutical

Segment by Type

  • Methyl Salicylate-based Patch
  • Rivastigmine Transdermal Patch
  • Fentanyl Transdermal Patch
  • Lidocaine Patch
  • Diclofenac Patch
  • Nicotine Transdermal Patch
  • Others

Segment by Application

  • Rx Channel
  • OTC Channel

By Region

  • North America
  • Europe
  • Japan
  • China
  • South America

TABLE OF CONTENTS

1 INDUSTRY OVERVIEW OF TRANSDERMAL PATCH 1

  • 1.1 Definition of Transdermal Patch 1
  • 1.2 Transdermal Patch Segment by Type 1
    • 1.2.1 Global Transdermal Patch Sales Growth Rate Comparison by Type (2015-2026) 2
    • 1.2.2 Methyl Salicylate-based Patch 3
    • 1.2.3 Rivastigmine Transdermal Patch 3
    • 1.2.4 Fentanyl Transdermal Patch 4
    • 1.2.5 Lidocaine Patch 4
    • 1.2.6 Diclofenac Patch 5
    • 1.2.7 Nicotine Transdermal Patch 5
  • 1.3 Transdermal Patch Segment by Application 6
    • 1.3.1 Global Transdermal Patch Sales Comparison by Application (2015-2026) 6
    • 1.3.2 Rx Channel 7
    • 1.3.3 OTC Channel 8
  • 1.4 Transdermal Patch Overall Market: 2015 VS 2020 VS 2026 8
    • 1.4.1 Global Transdermal Patch Revenue (2015-2026) 9
    • 1.4.2 Global Transdermal Patch Sales (2015-2026) 11
    • 1.4.3 North America Transdermal Patch Status and Prospect (2015-2026) 12
    • 1.4.4 Europe Transdermal Patch Status and Prospect (2015-2026) 13
    • 1.4.5 China Transdermal Patch Status and Prospect (2015-2026) 13
    • 1.4.6 Japan Transdermal Patch Status and Prospect (2015-2026) 14
    • 1.4.7 South America Transdermal Patch Status and Prospect (2015-2026) 15

2 MANUFACTURING COST STRUCTURE ANALYSIS 16

  • 2.1 Raw Material and Suppliers 16
  • 2.2 Manufacturing Cost Structure Analysis of Transdermal Patch 17
  • 2.3 Manufacturing Process Analysis of Transdermal Patch 17
  • 2.4 Industry Chain Structure of Transdermal Patch 20

3 DEVELOPMENT AND MANUFACTURING PLANTS ANALYSIS OF TRANSDERMAL PATCH 21

  • 3.1 Top Manufacturers Headquarters, Rank by Transdermal Patch Sales 21
  • 3.2 Global Transdermal Patch Manufacturing Plants Distribution 21
  • 3.3 Major Manufacturers Transdermal Patch Product Offered 22
  • 3.4 Recent Development and Expansion Plans 23

4 KEY FIGURES OF MAJOR MANUFACTURERS 25

  • 4.1 Global Top Manufacturers Transdermal Patch Sales Analysis 26
  • 4.2 Global Top Manufacturers Transdermal Patch Revenue Analysis 28
  • 4.3 Global Top Manufacturers Transdermal Patch Price Analysis 31
  • 4.4 Market Concentration Degree 32
  • 4.5 Primary Interviews with Key Transdermal Patch Players (Opinion Leaders) 33

5 TRANSDERMAL PATCH REGIONAL MARKET ANALYSIS 34

  • 5.1 Transdermal Patch Sales by Regions (2015-2020) 34
    • 5.1.1 Global Transdermal Patch Sales by Regions (2015-2020) 34
    • 5.1.2 Global Transdermal Patch Revenue by Regions 35
  • 5.2 Transdermal Patch Sales by Regions (2021-2026) 36
    • 5.2.1 Global Transdermal Patch Sales by Regions (2021-2026) 36
    • 5.2.2 Global Transdermal Patch Revenue by Regions 37
  • 5.3 North America Transdermal Patch Market Analysis 38
    • 5.3.1 North America Transdermal Patch Sales 38
    • 5.3.2 Key Players in North America 38
  • 5.4 Europe Transdermal Patch Market Analysis 39
    • 5.4.1 Europe Transdermal Patch Sales 39
    • 5.4.2 Key Players in Europe 39
  • 5.5 China Transdermal Patch Market Analysis 40
    • 5.5.1 China Transdermal Patch Sales 40
    • 5.5.2 Key Players in China 40
  • 5.6 Japan Transdermal Patch Market Analysis 41
    • 5.6.1 Japan Transdermal Patch Sales 41
    • 5.6.2 Key Players in Japan 41
  • 5.7 South America Transdermal Patch Market Analysis 42
    • 5.7.1 South America Transdermal Patch Sales 42
    • 5.7.2 Key Players in South America 42

6 TRANSDERMAL PATCH SEGMENT MARKET ANALYSIS (BY TYPE) 43

  • 6.1 Global Transdermal Patch Market Size by Type (2015-2020) 43
    • 6.1.1 Global Transdermal Patch Sales by Type (2015-2020) 43
    • 6.1.2 Global Transdermal Patch Revenue by Type (2015-2020) 43
  • 6.2 Global Transdermal Patch Market Size by Type (2021-2026) 44
    • 6.2.1 Global Transdermal Patch Sales by Type (2021-2026) 44
    • 6.2.2 Global Transdermal Patch Revenue by Type (2021-2026) 45
  • 6.3 Transdermal Patch Price by Type 45

7 TRANSDERMAL PATCH SEGMENT MARKET ANALYSIS (BY APPLICATION) 47

  • 7.1 Overview 47
  • 7.2 Global Transdermal Patch Sales Market Share by Application (2015-2020) 47
  • 7.3 Global Transdermal Patch Sales Market Share by Application (2021-2026) 47

8 TRANSDERMAL PATCH MANUFACTURERS ANALYSIS 49

  • 8.1 Hisamitsu Pharmaceutical 49
    • 8.1.1 Hisamitsu Pharmaceutical Corporation Information 49
    • 8.1.2 Hisamitsu Pharmaceutical Description and Business Overview 49
    • 8.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue, Ex-factory Price and Gross Margin (2015-2020) 50
    • 8.1.4 Hisamitsu Pharmaceutical Transdermal Patch Products Offered 50
  • 8.2 Johnson & Johnson 51
    • 8.2.1 Johnson & Johnson Corporation Information 51
    • 8.2.2 Johnson & Johnson Description and Business Overview 52
    • 8.2.3 Johnson & Johnson Pharmaceutical Transdermal Patch Sales, Revenue, Ex-factory Price and Gross Margin (2015-2020) 52
    • 8.2.4 Johnson & Johnson Transdermal Patch Products Offered 53
  • 8.3 Novartis 54
    • 8.3.1 Novartis Corporation Information 54
    • 8.3.2 Novartis Description and Business Overview 54
    • 8.3.3 Novartis Pharmaceutical Transdermal Patch Sales, Revenue, Ex-factory Price and Gross Margin (2015-2020) 55
    • 8.3.4 Novartis Transdermal Patch Products Offered 55
  • 8.4 UCB Pharma 56
    • 8.4.1 UCB Pharma Corporation Information 56
    • 8.4.2 UCB Pharma Description and Business Overview 56
    • 8.4.3 UCB Pharma Pharmaceutical Transdermal Patch Sales, Revenue, Ex-factory Price and Gross Margin (2015-2020) 57
    • 8.4.4 UCB Pharma Transdermal Patch Products Offered 57
  • 8.5 Mylan 57
    • 8.5.1 Mylan Corporation Information 57
    • 8.5.2 Mylan Description and Business Overview 58
    • 8.5.3 Mylan Pharmaceutical Transdermal Patch Sales, Revenue, Ex-factory Price and Gross Margin (2015-2020) 58
    • 8.5.4 Mylan Transdermal Patch Products Offered 58
  • 8.6 Teva Pharmaceutical 59
    • 8.6.1 Teva Pharmaceutical Corporation Information 59
    • 8.6.2 Teva Pharmaceutical Description and Business Overview 60
    • 8.6.3 Teva Pharmaceutical Pharmaceutical Transdermal Patch Sales, Revenue, Ex-factory Price and Gross Margin (2015-2020) 60
    • 8.6.4 Teva Pharmaceutical Transdermal Patch Products Offered 61
  • 8.7 Nitto Denko 61
    • 8.7.1 Nitto Denko Corporation Information 61
    • 8.7.2 Nitto Denko Description and Business Overview 62
    • 8.7.3 Nitto Denko Pharmaceutical Transdermal Patch Sales, Revenue, Ex-factory Price and Gross Margin (2015-2020) 62
    • 8.7.4 Nitto Denko Transdermal Patch Products Offered 62
  • 8.8 Grunenthal 63
    • 8.8.1 Grunenthal Corporation Information 63
    • 8.8.2 Grunenthal Description and Business Overview 63
    • 8.8.3 Grunenthal Pharmaceutical Transdermal Patch Sales, Revenue, Ex-factory Price and Gross Margin (2015-2020) 64
    • 8.8.4 Grunenthal Transdermal Patch Products Offered 64
  • 8.9 IBSA Group 64
    • 8.9.1 IBSA Group Corporation Information 64
    • 8.9.2 IBSA Group Description and Business Overview 65
    • 8.9.3 IBSA Group Pharmaceutical Transdermal Patch Sales, Revenue, Ex-factory Price and Gross Margin (2015-2020) 65
    • 8.9.4 IBSA Group Transdermal Patch Products Offered 66
  • 8.10 GSK 66
    • 8.10.1 GSK Corporation Information 66
    • 8.10.2 GSK Description and Business Overview 67
    • 8.10.3 GSK Pharmaceutical Transdermal Patch Sales, Revenue, Ex-factory Price and Gross Margin (2015-2020) 67
    • 8.10.4 GSK Transdermal Patch Products Offered 67
  • 8.11 Luye Pharma Group 68
    • 8.11.1 Luye Pharma Group Corporation Information 68
    • 8.11.2 Luye Pharma Group Description and Business Overview 68
    • 8.11.3 Luye Pharma Group Pharmaceutical Transdermal Patch Sales, Revenue, Ex-factory Price and Gross Margin (2015-2020) 69
    • 8.11.4 Luye Pharma Group Transdermal Patch Products Offered 69
  • 8.12 Pfizer 70
    • 8.12.1 Pfizer Corporation Information 70
    • 8.12.2 Pfizer Description and Business Overview 70
    • 8.12.3 Pfizer Pharmaceutical Transdermal Patch Sales, Revenue, Ex-factory Price and Gross Margin (2015-2020) 70
    • 8.12.4 Pfizer Transdermal Patch Products Offered 71
  • 8.13 Chattem 71
    • 8.13.1 Chattem Corporation Information 71
    • 8.13.2 Chattem Description and Business Overview 72
    • 8.13.3 Chattem Pharmaceutical Transdermal Patch Sales, Revenue, Ex-factory Price and Gross Margin (2015-2020) 72
    • 8.13.4 Chattem Transdermal Patch Products Offered 73
  • 8.14 Dr Reddy's Laboratories 73
    • 8.14.1 Dr Reddy's Laboratories Corporation Information 73
    • 8.14.2 Dr Reddy's Laboratories Description and Business Overview 74
    • 8.14.3 Dr Reddy's Laboratories Pharmaceutical Transdermal Patch Sales, Revenue, Ex-factory Price and Gross Margin (2015-2020) 74
    • 8.14.4 Dr Reddy's Laboratories Transdermal Patch Products Offered 74
  • 8.15 Bayer 75
    • 8.15.1 Bayer Corporation Information 75
    • 8.15.2 Bayer Description and Business Overview 76
    • 8.15.3 Bayer Pharmaceutical Transdermal Patch Sales, Revenue, Ex-factory Price and Gross Margin (2015-2020) 76
    • 8.15.4 Bayer Transdermal Patch Products Offered 76
  • 8.16 Mundipharma 77
    • 8.16.1 Mundipharma Corporation Information 77
    • 8.16.2 Mundipharma Description and Business Overview 78
    • 8.16.3 Mundipharma Pharmaceutical Transdermal Patch Sales, Revenue, Ex-factory Price and Gross Margin (2015-2020) 78
    • 8.16.4 Mundipharma Transdermal Patch Products Offered 78
  • 8.17 Endo International 79
    • 8.17.1 Endo International Corporation Information 79
    • 8.17.2 Endo International Description and Business Overview 80
    • 8.17.3 Endo International Pharmaceutical Transdermal Patch Sales, Revenue, Ex-factory Price and Gross Margin (2015-2020) 80
    • 8.17.4 Endo International Transdermal Patch Products Offered 80
  • 8.18 Beijing Tide Pharmaceutical 81
    • 8.18.1 Beijing Tide Pharmaceutical Corporation Information 81
    • 8.18.2 Beijing Tide Pharmaceutical Description and Business Overview 82
    • 8.18.3 Beijing Tide Pharmaceutical Pharmaceutical Transdermal Patch Sales, Revenue, Ex-factory Price and Gross Margin (2015-2020) 82
    • 8.18.4 Beijing Tide Pharmaceutical Transdermal Patch Products Offered 83

9 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS 84

  • 9.1 Transdermal Patch Marketing Channel 84
    • 9.1.1 Direct Channels 84
    • 9.1.2 Indirect Channels 84
  • 9.2 Transdermal Patch Distributors List 85
  • 9.3 Transdermal Patch Customers 87

10 MARKET DYNAMICS 90

  • 10.1 Transdermal Patch Market Trends 90
  • 10.2 Transdermal Patch Opportunities and Drivers 90
  • 10.3 Transdermal Patch Challenges 91
  • 10.4 Porter's Five Forces Analysis 92

11 CONCLUSION 94

12 APPENDIX 96

  • 12.1 Methodology/Research Approach 96
    • 12.1.1 Research Programs/Design 96
    • 12.1.2 Market Size Estimation 97
    • 12.1.3 Market Breakdown and Data Triangulation 98
  • 12.2 Data Source 99
    • 12.2.1 Secondary Sources 99
    • 12.2.2 Primary Sources 100
  • 12.3 Author List 102
  • 12.4 Disclaimer 102
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.